Funding

Albert Raises $55M in Series B Funding Led by TCV

Oct 14, 2026 | By Devin Jacobs

Albert Raises $55M in Series B Funding Led by TCV

SUMMARY

  • Albert raised $55M in Series B funding led by TCV.
  • Funds will support growth and product development.
  • Albert builds AI tools for chemistry research.

Albert, an Oakland, CA-based provider of a chemistry-native AI operating system for R&D, has raised $55 million in a Series B funding round led by TCV.

The round also saw participation from new investors Delta-v Capital, Socium Ventures, HighSage Ventures, Coral Capital, and Legion VC, as well as existing investors Coatue, J.P. Morgan Growth Equity Partners, Index Ventures, and Applied Ventures, LLC.

The company will use the funding to expand operations and product development.

What is Albert?

Albert develops a chemistry-focused AI operating system that helps scientists and materials researchers speed up product development and discovery.

Read More:Mind Robotics Appoints Doug Field as President

Its platform, Albert Invent, allows scientists to use natural language to search research knowledge, suggest chemical formulations, design experiments and analyze complex data. It helps teams reduce repeated work and make research decisions faster.

The platform is designed for large organizations that need specialized scientific AI, along with data security, regulatory compliance and access controls. Its customers and partners include AkzoNobel, Avient, BASF, Chemours, Clorox, Henkel, Kenvue and Nouryon.

About Albert

RECOMMENDED FOR YOU

How Much Funding Has Albert Raised?

Albert has raised $55 million in its latest Series B funding round. Details of previous funding rounds and total funding to date were not provided.

Who Invested in Albert’s Series B Round?

The $55 million Series B round was led by TCV.

New investors include:

  • Delta-v Capital
  • Socium Ventures
  • HighSage Ventures
  • Coral Capital
  • Legion VC

Existing investors that also participated include:

  • Coatue
  • J.P. Morgan Growth Equity Partners
  • Index Ventures
  • Applied Ventures, LLC

Why the Funding Matters

Albert will use the funding to expand its operations and continue developing its chemistry-focused AI platform.

The investment will support its efforts to help enterprise R&D teams accelerate scientific discovery while meeting the security and compliance requirements of large organizations.

Albert funding

Who founded Albert?

Albert was founded in 2022 by Nick Talken and Ken Kisner.

The company is based in Oakland, California, and develops AI technology for chemistry and materials science research.

“R&D in chemistry still runs largely on spreadsheets and institutional memory,” said Morgan Gerlack, Partner, TCV. “Albert turns decades of lab data into faster discovery, and it represents what we think the future of vertical AI should look like.”

Market and Business Growth

Albert works with companies across the chemicals and materials sectors, including BASF, AkzoNobel, Chemours, Clorox and Henkel.

The company has developed FormBench, a benchmark for evaluating AI performance in formulation chemistry. It has also introduced Valence, a chemistry-focused AI model that, according to the company, is 45 times more accurate than general-purpose AI at retrieving answers to scientific queries in its research evaluation.

What Happens Next?

Albert plans to expand its operations and further develop its chemistry-native AI technology. The company aims to help enterprise research teams improve formulation development, experiment design and scientific data analysis.

Read More:NYC-Based Marsh Appoints Nicole Delimitros as President

Recommended Stories for You